UniProtKB - P40763 (STAT3_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Signal transducer and activator of transcription 3
Gene
STAT3
Organism
Homo sapiens (Human)
Status
Functioni
Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors (PubMed:10688651, PubMed:12359225, PubMed:12873986, PubMed:15194700, PubMed:17344214, PubMed:18242580, PubMed:23084476). Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene (PubMed:17344214). May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4 (PubMed:12873986). Binds to the interleukin-6 (IL-6)-responsive elements identified in the promoters of various acute-phase protein genes (PubMed:12359225). Activated by IL31 through IL31RA (PubMed:15194700). Acts as a regulator of inflammatory response by regulating differentiation of naive CD4+ T-cells into T-helper Th17 or regulatory T-cells (Treg): deacetylation and oxidation of lysine residues by LOXL3, leads to disrupt STAT3 dimerization and inhibit its transcription activity (PubMed:28065600). Involved in cell cycle regulation by inducing the expression of key genes for the progression from G1 to S phase, such as CCND1 (PubMed:17344214). Mediates the effects of LEP on melanocortin production, body energy homeostasis and lactation (By similarity). May play an apoptotic role by transctivating BIRC5 expression under LEP activation (PubMed:18242580). Cytoplasmic STAT3 represses macroautophagy by inhibiting EIF2AK2/PKR activity (PubMed:23084476). Plays a crucial role in basal beta cell functions, such as regulation of insulin secretion (By similarity).By similarity8 Publications
Miscellaneous
Involved in the gp130-mediated signaling pathway.
GO - Molecular functioni
- CCR5 chemokine receptor binding Source: Ensembl
- chromatin DNA binding Source: UniProtKB
- DNA binding Source: UniProtKB
- glucocorticoid receptor binding Source: Ensembl
- identical protein binding Source: IntAct
- protein dimerization activity Source: UniProtKB
- protein homodimerization activity Source: UniProtKB
- protein kinase binding Source: UniProtKB
- protein phosphatase binding Source: UniProtKB
- RNA polymerase II core promoter proximal region sequence-specific DNA binding Source: BHF-UCL
- RNA polymerase II repressing transcription factor binding Source: BHF-UCL
- RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding Source: BHF-UCL
- signal transducer activity Source: ProtInc
- transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding Source: BHF-UCL
- transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding Source: BHF-UCL
- transcription factor activity, sequence-specific DNA binding Source: UniProtKB
- transcription factor binding Source: UniProtKB
- transcription regulatory region DNA binding Source: BHF-UCL
GO - Biological processi
- acute-phase response Source: Ensembl
- aging Source: Ensembl
- astrocyte differentiation Source: UniProtKB
- cell proliferation Source: Ensembl
- cellular response to hormone stimulus Source: BHF-UCL
- cellular response to leptin stimulus Source: UniProtKB
- cellular response to organic cyclic compound Source: Ensembl
- cytokine-mediated signaling pathway Source: UniProtKB
- eating behavior Source: UniProtKB
- energy homeostasis Source: UniProtKB
- eye photoreceptor cell differentiation Source: UniProtKB
- glucose homeostasis Source: UniProtKB
- growth hormone receptor signaling pathway Source: BHF-UCL
- inflammatory response Source: UniProtKB
- interleukin-6-mediated signaling pathway Source: UniProtKB
- intracellular receptor signaling pathway Source: BHF-UCL
- JAK-STAT cascade Source: UniProtKB
- JAK-STAT cascade involved in growth hormone signaling pathway Source: BHF-UCL
- leptin-mediated signaling pathway Source: UniProtKB
- miRNA mediated inhibition of translation Source: BHF-UCL
- movement of cell or subcellular component Source: ProtInc
- mRNA transcription from RNA polymerase II promoter Source: Ensembl
- negative regulation of apoptotic process Source: CACAO
- negative regulation of cell proliferation Source: Ensembl
- negative regulation of glycolytic process Source: Ensembl
- negative regulation of hydrogen peroxide biosynthetic process Source: Ensembl
- negative regulation of neuron death Source: Ensembl
- negative regulation of neuron migration Source: Ensembl
- negative regulation of stem cell differentiation Source: Ensembl
- negative regulation of transcription from RNA polymerase II promoter Source: ProtInc
- nervous system development Source: ProtInc
- phosphorylation Source: UniProtKB
- positive regulation of ATP biosynthetic process Source: Ensembl
- positive regulation of cell proliferation Source: Ensembl
- positive regulation of erythrocyte differentiation Source: UniProtKB
- positive regulation of gene expression Source: BHF-UCL
- positive regulation of gene silencing by miRNA Source: BHF-UCL
- positive regulation of growth factor dependent skeletal muscle satellite cell proliferation Source: Ensembl
- positive regulation of metalloendopeptidase activity Source: BHF-UCL
- positive regulation of Notch signaling pathway Source: UniProtKB
- positive regulation of pri-miRNA transcription from RNA polymerase II promoter Source: BHF-UCL
- positive regulation of transcription, DNA-templated Source: BHF-UCL
- positive regulation of transcription from RNA polymerase II promoter Source: BHF-UCL
- protein import into nucleus Source: UniProtKB
- radial glial cell differentiation Source: UniProtKB
- regulation of cell cycle Source: UniProtKB
- regulation of feeding behavior Source: UniProtKB
- regulation of mitochondrial membrane permeability Source: Ensembl
- regulation of multicellular organism growth Source: Ensembl
- regulation of transcription, DNA-templated Source: UniProtKB
- regulation of transcription from RNA polymerase II promoter Source: UniProtKB
- response to drug Source: Ensembl
- response to estradiol Source: BHF-UCL
- response to ethanol Source: Ensembl
- response to leptin Source: UniProtKB
- sexual reproduction Source: UniProtKB
- signal transduction Source: ProtInc
- somatic stem cell population maintenance Source: Reactome
- temperature homeostasis Source: UniProtKB
- T-helper 17 cell lineage commitment Source: UniProtKB
- viral process Source: UniProtKB-KW
Keywordsi
| Molecular function | Activator, DNA-binding |
| Biological process | Host-virus interaction, Transcription, Transcription regulation |
Enzyme and pathway databases
| Reactomei | R-HSA-1433557. Signaling by SCF-KIT. R-HSA-1839117. Signaling by cytosolic FGFR1 fusion mutants. R-HSA-186763. Downstream signal transduction. R-HSA-198745. Signalling to STAT3. R-HSA-2559582. Senescence-Associated Secretory Phenotype (SASP). R-HSA-2586552. Signaling by Leptin. R-HSA-2892247. POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation. R-HSA-390471. Association of TriC/CCT with target proteins during biosynthesis. R-HSA-452723. Transcriptional regulation of pluripotent stem cells. R-HSA-6783589. Interleukin-6 family signaling. R-HSA-6783783. Interleukin-10 signaling. R-HSA-6785807. Interleukin-4 and 13 signaling. R-HSA-8849474. PTK6 Activates STAT3. R-HSA-8875791. MET activates STAT3. R-HSA-982772. Growth hormone receptor signaling. |
| SignaLinki | P40763. |
| SIGNORi | P40763. |
Names & Taxonomyi
| Protein namesi | Recommended name: Signal transducer and activator of transcription 3ImportedAlternative name(s): Acute-phase response factor |
| Gene namesi | |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:11364. STAT3. |
Subcellular locationi
- Cytoplasm
- Nucleus 1 Publication
Note: Shuttles between the nucleus and the cytoplasm. Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4. Constitutive nuclear presence is independent of tyrosine phosphorylation. Predominantly present in the cytoplasm without stimuli. Upon leukemia inhibitory factor (LIF) stimulation, accumulates in the nucleus. The complex composed of BART and ARL2 plays an important role in the nuclear translocation and retention of STAT3. Identified in a complex with LYN and PAG1.
GO - Cellular componenti
- cytoplasm Source: UniProtKB
- cytosol Source: HPA
- mitochondrial inner membrane Source: Ensembl
- nuclear chromatin Source: BHF-UCL
- nucleoplasm Source: HPA
- nucleus Source: UniProtKB
- plasma membrane Source: UniProtKB
- RNA polymerase II transcription factor complex Source: BHF-UCL
Keywords - Cellular componenti
Cytoplasm, NucleusPathology & Biotechi
Involvement in diseasei
Hyperimmunoglobulin E recurrent infection syndrome, autosomal dominant (AD-HIES)4 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA rare disorder of immunity and connective tissue characterized by immunodeficiency, chronic eczema, recurrent Staphylococcal infections, increased serum IgE, eosinophilia, distinctive coarse facial appearance, abnormal dentition, hyperextensibility of the joints, and bone fractures.
See also OMIM:147060| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_037365 | 382 | R → L in AD-HIES. 1 PublicationCorresponds to variant dbSNP:rs113994136Ensembl. | 1 | |
| Natural variantiVAR_037366 | 382 | R → Q in AD-HIES; loss of function. 2 PublicationsCorresponds to variant dbSNP:rs113994136Ensembl. | 1 | |
| Natural variantiVAR_037367 | 382 | R → W in AD-HIES; loss of function; reduced DNA-binding ability. 3 PublicationsCorresponds to variant dbSNP:rs113994135Ensembl. | 1 | |
| Natural variantiVAR_037368 | 384 | F → L in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037369 | 384 | F → S in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037370 | 389 | T → I in AD-HIES; loss of function. 2 PublicationsCorresponds to variant dbSNP:rs397514766Ensembl. | 1 | |
| Natural variantiVAR_075414 | 395 | N → Y in AD-HIES; unknown pathological significance; reduced DNA-binding ability. 1 Publication | 1 | |
| Natural variantiVAR_037371 | 423 | R → Q in AD-HIES. 1 PublicationCorresponds to variant dbSNP:rs113994137Ensembl. | 1 | |
| Natural variantiVAR_075415 | 425 | N → Y in AD-HIES; unknown pathological significance; reduced DNA-binding ability. 1 Publication | 1 | |
| Natural variantiVAR_037372 | 437 | H → Y in AD-HIES; loss of function. 1 Publication | 1 | |
| Natural variantiVAR_037373 | 463 | Missing in AD-HIES; loss of function. 2 Publications | 1 | |
| Natural variantiVAR_037375 | 611 | S → N in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037376 | 621 | F → V in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037377 | 622 | T → I in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037378 | 637 | V → L in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037379 | 637 | V → M in AD-HIES; reduced DNA-binding ability. 2 PublicationsCorresponds to variant dbSNP:rs113994139Ensembl. | 1 | |
| Natural variantiVAR_037380 | 644 | Missing in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037381 | 657 | Y → C in AD-HIES; reduced DNA-binding ability. 2 PublicationsCorresponds to variant dbSNP:rs193922721Ensembl. | 1 |
Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1)2 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA disorder characterized by early childhood onset of a spectrum of autoimmune manifestations affecting multiple organs, including insulin-dependent diabetes mellitus and autoimmune enteropathy or celiac disease. Other features include short stature, non-specific dermatitis, hypothyroidism, autoimmune arthritis, and delayed puberty.
See also OMIM:615952| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_078445 | 330 | P → S in ADMIO1; increases transcriptional activity; increases binding to ISL1 promoter region; decreases glucose stimulated insulin secretion. 1 Publication | 1 | |
| Natural variantiVAR_071885 | 392 | K → R in ADMIO1. 1 PublicationCorresponds to variant dbSNP:rs587777648Ensembl. | 1 | |
| Natural variantiVAR_071886 | 646 | N → K in ADMIO1. 1 PublicationCorresponds to variant dbSNP:rs587777649Ensembl. | 1 | |
| Natural variantiVAR_071887 | 658 | K → N in ADMIO1. 1 PublicationCorresponds to variant dbSNP:rs587777650Ensembl. | 1 | |
| Natural variantiVAR_071888 | 716 | T → M in ADMIO1. 1 PublicationCorresponds to variant dbSNP:rs869312892Ensembl. | 1 |
Mutagenesis
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Mutagenesisi | 434 – 435 | EE → AA: Inhibits leptin-mediated transactivation of CCND1 promoter. No effect on interaction with INPP5F. 2 Publications | 2 | |
| Mutagenesisi | 705 | Y → F: Inhibits leptin-mediated transactivation of CCND1 promoter. 1 Publication | 1 |
Keywords - Diseasei
Diabetes mellitus, Disease mutation, DwarfismOrganism-specific databases
| DisGeNETi | 6774. |
| MalaCardsi | STAT3. |
| MIMi | 147060. phenotype. 615952. phenotype. |
| OpenTargetsi | ENSG00000168610. |
| Orphaneti | 2314. Autosomal dominant hyper-IgE syndrome. |
| PharmGKBi | PA337. |
Chemistry databases
| ChEMBLi | CHEMBL4026. |
Polymorphism and mutation databases
| BioMutai | STAT3. |
| DMDMi | 48429227. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Initiator methioninei | RemovedCombined sources | |||
| ChainiPRO_0000182417 | 2 – 770 | Signal transducer and activator of transcription 3Add BLAST | 769 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length | |
|---|---|---|---|---|---|
| Modified residuei | 2 | N-acetylalanineCombined sources | 1 | ||
| Modified residuei | 601 | Allysine; alternate1 Publication | 1 | ||
| Modified residuei | 601 | N6-acetyllysine; alternate1 Publication | 1 | ||
| Modified residuei | 615 | Allysine; alternate1 Publication | 1 | ||
| Modified residuei | 615 | N6-acetyllysine; alternate1 Publication | 1 | ||
| Modified residuei | 631 | Allysine; alternate1 Publication | 1 | ||
| Modified residuei | 631 | N6-acetyllysine; alternate1 Publication | 1 | ||
| Modified residuei | 685 | Allysine; alternate1 Publication | 1 | ||
| Modified residuei | 685 | N6-acetyllysine; alternate1 Publication | 1 | ||
| Modified residuei | 705 | Phosphotyrosine; by FER and PTK6Combined sources4 Publications | 1 | ||
| Modified residuei | 707 | N6-acetyllysine1 Publication | 1 | ||
| Modified residuei | 714 | PhosphothreonineCombined sources | 1 | ||
| Modified residuei | 727 | Phosphoserine; by DYRK2, NLK, NEK6, IRAK1, RPS6KA5, ZIPK/DAPK3 and PKC/PRKCECombined sources7 Publications | 1 | ||
| Isoform Del-701 (identifier: P40763-2) | |||||
| Modified residuei | 704 | PhosphotyrosineCombined sources | 1 | ||
Post-translational modificationi
Tyrosine phosphorylated upon stimulation with EGF. Tyrosine phosphorylated in response to constitutively activated FGFR1, FGFR2, FGFR3 and FGFR4 (By similarity). Activated through tyrosine phosphorylation by BMX. Tyrosine phosphorylated in response to IL6, IL11, LIF, CNTF, KITLG/SCF, CSF1, EGF, PDGF, IFN-alpha, LEP and OSM. Activated KIT promotes phosphorylation on tyrosine residues and subsequent translocation to the nucleus. Phosphorylated on serine upon DNA damage, probably by ATM or ATR. Serine phosphorylation is important for the formation of stable DNA-binding STAT3 homodimers and maximal transcriptional activity. ARL2BP may participate in keeping the phosphorylated state of STAT3 within the nucleus. Upon LPS challenge, phosphorylated within the nucleus by IRAK1. Upon erythropoietin treatment, phosphorylated on Ser-727 by RPS6KA5. Phosphorylation at Tyr-705 by PTK6 or FER leads to an increase of its transcriptional activity. Dephosphorylation on tyrosine residues by PTPN2 negatively regulates IL6/interleukin-6 signaling.By similarity13 Publications
Acetylated on lysine residues by CREBBP. Deacetylation by LOXL3 leads to disrupt STAT3 dimerization and inhibit STAT3 transcription activity (PubMed:28065600). Oxidation of lysine residues to allysine on STAT3 preferentially takes place on lysine residues that are acetylated (PubMed:28065600).1 Publication
Some lysine residues are oxidized to allysine by LOXL3, leading to disrupt STAT3 dimerization and inhibit STAT3 transcription activity (PubMed:28065600). Oxidation of lysine residues to allysine on STAT3 preferentially takes place on lysine residues that are acetylated (PubMed:28065600).1 Publication
Keywords - PTMi
Acetylation, PhosphoproteinProteomic databases
| EPDi | P40763. |
| MaxQBi | P40763. |
| PaxDbi | P40763. |
| PeptideAtlasi | P40763. |
| PRIDEi | P40763. |
PTM databases
| iPTMneti | P40763. |
| PhosphoSitePlusi | P40763. |
Miscellaneous databases
| PMAP-CutDBi | P40763. |
Expressioni
Tissue specificityi
Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
Gene expression databases
| Bgeei | ENSG00000168610. |
| CleanExi | HS_STAT3. |
| ExpressionAtlasi | P40763. baseline and differential. |
| Genevisiblei | P40763. HS. |
Organism-specific databases
| HPAi | CAB003859. CAB068241. CAB068242. HPA001671. HPA058603. |
Interactioni
Subunit structurei
Forms a homodimer or a heterodimer with a related family member (at least STAT1) (PubMed:28065600). Interacts with IL31RA, NCOA1, PELP1, SIPAR, SOCS7, STATIP1 and TMF1. Interacts with IL23R in presence of IL23. Interacts (via SH2 domain) with NLK. Interacts with ARL2BP; the interaction is enhanced by LIF and JAK1 expression (By similarity). Interacts with KPNA4 and KPNA5; KPNA4 may be the primary mediator of nuclear import (By similarity). Interacts with CAV2; the interaction is increased on insulin-induced tyrosine phosphorylation of CAV2 and leads to STAT3 activation (By similarity). Interacts with ARL2BP; interaction is enhanced with ARL2. Interacts with NEK6 (By similarity). Binds to CDK9 when activated and nuclear. Interacts with BMX. Interacts with ZIPK/DAPK3. Interacts with PIAS3; the interaction occurs on stimulation by IL6, CNTF or OSM and inhibits the DNA binding activity of STAT3. In prostate cancer cells, interacts with STAT3 and promotes DNA binding activity of STAT3. Interacts with STMN3, antagonizing its microtubule-destabilizing activity. Interacts with the 'Lys-129' acetylated form of BIRC5/survivin. Interacts with FER. Interacts (via SH2 domain) with EIF2AK2/PKR (via the kinase catalytic domain). Interacts with STAT3; the interaction is independent of STAT3 TYR-705 phosphorylation status (PubMed:25476455). Interacts with FGFR4 (PubMed:26675719).By similarity20 Publications
(Microbial infection) Interacts with HCV core protein.1 Publication
Binary interactionsi
GO - Molecular functioni
- CCR5 chemokine receptor binding Source: Ensembl
- glucocorticoid receptor binding Source: Ensembl
- identical protein binding Source: IntAct
- protein dimerization activity Source: UniProtKB
- protein homodimerization activity Source: UniProtKB
- protein kinase binding Source: UniProtKB
- protein phosphatase binding Source: UniProtKB
- RNA polymerase II repressing transcription factor binding Source: BHF-UCL
- transcription factor binding Source: UniProtKB
Protein-protein interaction databases
| BioGridi | 112651. 242 interactors. |
| DIPi | DIP-33584N. |
| IntActi | P40763. 160 interactors. |
| MINTi | MINT-146801. |
| STRINGi | 9606.ENSP00000264657. |
Chemistry databases
| BindingDBi | P40763. |
Structurei
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 5AX3 | X-ray | 2.98 | B | 571-582 | [»] | |
| 5U5S | NMR | - | B | 81-92 | [»] | |
| ProteinModelPortali | P40763. | |||||
| SMRi | P40763. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 580 – 670 | SH2PROSITE-ProRule annotationAdd BLAST | 91 |
Motif
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Motifi | 150 – 162 | Essential for nuclear importAdd BLAST | 13 |
Sequence similaritiesi
Belongs to the transcription factor STAT family.Curated
Keywords - Domaini
SH2 domainPhylogenomic databases
| eggNOGi | KOG3667. Eukaryota. ENOG410XPN8. LUCA. |
| GeneTreei | ENSGT00760000119236. |
| HOGENOMi | HOG000220792. |
| HOVERGENi | HBG055669. |
| InParanoidi | P40763. |
| KOi | K04692. |
| OMAi | NSMSFAE. |
| OrthoDBi | EOG091G03O3. |
| PhylomeDBi | P40763. |
| TreeFami | TF318648. |
Family and domain databases
| Gene3Di | 1.10.532.10. 1 hit. 2.60.40.630. 1 hit. 3.30.505.10. 1 hit. |
| InterProi | View protein in InterPro IPR008967. p53-like_TF_DNA-bd. IPR000980. SH2. IPR001217. STAT. IPR013800. STAT_TF_alpha. IPR015988. STAT_TF_coiled-coil. IPR013801. STAT_TF_DNA-bd. IPR012345. STAT_TF_DNA-bd_sub. IPR013799. STAT_TF_prot_interaction. |
| PANTHERi | PTHR11801. PTHR11801. 1 hit. |
| Pfami | View protein in Pfam PF00017. SH2. 1 hit. PF01017. STAT_alpha. 1 hit. PF02864. STAT_bind. 1 hit. PF02865. STAT_int. 1 hit. |
| SMARTi | View protein in SMART SM00964. STAT_int. 1 hit. |
| SUPFAMi | SSF47655. SSF47655. 1 hit. SSF48092. SSF48092. 1 hit. SSF49417. SSF49417. 1 hit. SSF55550. SSF55550. 1 hit. |
| PROSITEi | View protein in PROSITE PS50001. SH2. 1 hit. |
Sequences (3)i
Sequence statusi: Complete.
Sequence processingi: The displayed sequence is further processed into a mature form.
This entry describes 3 isoformsi produced by alternative splicing. AlignAdd to basket
Isoform 1 (identifier: P40763-1) [UniParc]FASTAAdd to basket
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MAQWNQLQQL DTRYLEQLHQ LYSDSFPMEL RQFLAPWIES QDWAYAASKE
60 70 80 90 100
SHATLVFHNL LGEIDQQYSR FLQESNVLYQ HNLRRIKQFL QSRYLEKPME
110 120 130 140 150
IARIVARCLW EESRLLQTAA TAAQQGGQAN HPTAAVVTEK QQMLEQHLQD
160 170 180 190 200
VRKRVQDLEQ KMKVVENLQD DFDFNYKTLK SQGDMQDLNG NNQSVTRQKM
210 220 230 240 250
QQLEQMLTAL DQMRRSIVSE LAGLLSAMEY VQKTLTDEEL ADWKRRQQIA
260 270 280 290 300
CIGGPPNICL DRLENWITSL AESQLQTRQQ IKKLEELQQK VSYKGDPIVQ
310 320 330 340 350
HRPMLEERIV ELFRNLMKSA FVVERQPCMP MHPDRPLVIK TGVQFTTKVR
360 370 380 390 400
LLVKFPELNY QLKIKVCIDK DSGDVAALRG SRKFNILGTN TKVMNMEESN
410 420 430 440 450
NGSLSAEFKH LTLREQRCGN GGRANCDASL IVTEELHLIT FETEVYHQGL
460 470 480 490 500
KIDLETHSLP VVVISNICQM PNAWASILWY NMLTNNPKNV NFFTKPPIGT
510 520 530 540 550
WDQVAEVLSW QFSSTTKRGL SIEQLTTLAE KLLGPGVNYS GCQITWAKFC
560 570 580 590 600
KENMAGKGFS FWVWLDNIID LVKKYILALW NEGYIMGFIS KERERAILST
610 620 630 640 650
KPPGTFLLRF SESSKEGGVT FTWVEKDISG KTQIQSVEPY TKQQLNNMSF
660 670 680 690 700
AEIIMGYKIM DATNILVSPL VYLYPDIPKE EAFGKYCRPE SQEHPEADPG
710 720 730 740 750
SAAPYLKTKF ICVTPTTCSN TIDLPMSPRT LDSLMQFGNN GEGAEPSAGG
760 770
QFESLTFDME LTSECATSPM
Isoform Del-701 (identifier: P40763-2) [UniParc]FASTAAdd to basket
The sequence of this isoform differs from the canonical sequence as follows:
701-701: Missing.
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 133 | T → A in BAF84622 (PubMed:14702039).Curated | 1 | |
| Sequence conflicti | 288 | Q → H in AAA58374 (PubMed:7512451).Curated | 1 | |
| Sequence conflicti | 460 | P → S in AAA58374 (PubMed:7512451).Curated | 1 | |
| Sequence conflicti | 548 | K → N in AAA58374 (PubMed:7512451).Curated | 1 | |
| Sequence conflicti | 652 | E → V in BAF84622 (PubMed:14702039).Curated | 1 | |
| Sequence conflicti | 667 | V → L in AAA58374 (PubMed:7512451).Curated | 1 | |
| Sequence conflicti | 730 | T → A in AAA58374 (PubMed:7512451).Curated | 1 |
Natural variant
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_018683 | 32 | Q → K. Corresponds to variant dbSNP:rs1803125Ensembl. | 1 | |
| Natural variantiVAR_018679 | 143 | M → I1 PublicationCorresponds to variant dbSNP:rs17878478Ensembl. | 1 | |
| Natural variantiVAR_078445 | 330 | P → S in ADMIO1; increases transcriptional activity; increases binding to ISL1 promoter region; decreases glucose stimulated insulin secretion. 1 Publication | 1 | |
| Natural variantiVAR_037365 | 382 | R → L in AD-HIES. 1 PublicationCorresponds to variant dbSNP:rs113994136Ensembl. | 1 | |
| Natural variantiVAR_037366 | 382 | R → Q in AD-HIES; loss of function. 2 PublicationsCorresponds to variant dbSNP:rs113994136Ensembl. | 1 | |
| Natural variantiVAR_037367 | 382 | R → W in AD-HIES; loss of function; reduced DNA-binding ability. 3 PublicationsCorresponds to variant dbSNP:rs113994135Ensembl. | 1 | |
| Natural variantiVAR_037368 | 384 | F → L in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037369 | 384 | F → S in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037370 | 389 | T → I in AD-HIES; loss of function. 2 PublicationsCorresponds to variant dbSNP:rs397514766Ensembl. | 1 | |
| Natural variantiVAR_071885 | 392 | K → R in ADMIO1. 1 PublicationCorresponds to variant dbSNP:rs587777648Ensembl. | 1 | |
| Natural variantiVAR_075414 | 395 | N → Y in AD-HIES; unknown pathological significance; reduced DNA-binding ability. 1 Publication | 1 | |
| Natural variantiVAR_037371 | 423 | R → Q in AD-HIES. 1 PublicationCorresponds to variant dbSNP:rs113994137Ensembl. | 1 | |
| Natural variantiVAR_075415 | 425 | N → Y in AD-HIES; unknown pathological significance; reduced DNA-binding ability. 1 Publication | 1 | |
| Natural variantiVAR_037372 | 437 | H → Y in AD-HIES; loss of function. 1 Publication | 1 | |
| Natural variantiVAR_037373 | 463 | Missing in AD-HIES; loss of function. 2 Publications | 1 | |
| Natural variantiVAR_037374 | 561 | F → Y1 PublicationCorresponds to variant dbSNP:rs1064116Ensembl. | 1 | |
| Natural variantiVAR_037375 | 611 | S → N in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037376 | 621 | F → V in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037377 | 622 | T → I in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037378 | 637 | V → L in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_037379 | 637 | V → M in AD-HIES; reduced DNA-binding ability. 2 PublicationsCorresponds to variant dbSNP:rs113994139Ensembl. | 1 | |
| Natural variantiVAR_037380 | 644 | Missing in AD-HIES. 1 Publication | 1 | |
| Natural variantiVAR_071886 | 646 | N → K in ADMIO1. 1 PublicationCorresponds to variant dbSNP:rs587777649Ensembl. | 1 | |
| Natural variantiVAR_037381 | 657 | Y → C in AD-HIES; reduced DNA-binding ability. 2 PublicationsCorresponds to variant dbSNP:rs193922721Ensembl. | 1 | |
| Natural variantiVAR_071887 | 658 | K → N in ADMIO1. 1 PublicationCorresponds to variant dbSNP:rs587777650Ensembl. | 1 | |
| Natural variantiVAR_071888 | 716 | T → M in ADMIO1. 1 PublicationCorresponds to variant dbSNP:rs869312892Ensembl. | 1 |
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_010474 | 701 | Missing in isoform Del-701. 1 Publication | 1 | |
| Alternative sequenceiVSP_055918 | 716 – 722 | TTCSNTI → FIDAVWK in isoform 3. 1 Publication | 7 | |
| Alternative sequenceiVSP_055919 | 723 – 770 | Missing in isoform 3. 1 PublicationAdd BLAST | 48 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | L29277 mRNA. Translation: AAA58374.1. AJ012463 mRNA. Translation: CAA10032.1. JB252046 mRNA. No translation available. AK291933 mRNA. Translation: BAF84622.1. AY572796 Genomic DNA. Translation: AAS66986.1. AC087691 Genomic DNA. No translation available. CH471152 Genomic DNA. Translation: EAW60822.1. BC000627 mRNA. Translation: AAH00627.1. BC014482 mRNA. Translation: AAH14482.1. AF029311 mRNA. Translation: AAB84254.1. |
| CCDSi | CCDS32656.1. [P40763-1] CCDS32657.1. [P40763-2] CCDS59288.1. [P40763-3] |
| PIRi | A54444. |
| RefSeqi | NP_003141.2. NM_003150.3. [P40763-2] NP_644805.1. NM_139276.2. [P40763-1] NP_998827.1. NM_213662.1. [P40763-3] XP_005257673.2. XM_005257616.3. [P40763-2] XP_005257674.2. XM_005257617.3. [P40763-1] XP_011523447.1. XM_011525145.2. [P40763-1] XP_011523448.1. XM_011525146.2. [P40763-3] XP_016880461.1. XM_017024972.1. [P40763-3] XP_016880464.1. XM_017024975.1. [P40763-2] |
| UniGenei | Hs.463059. |
Genome annotation databases
| Ensembli | ENST00000264657; ENSP00000264657; ENSG00000168610. [P40763-1] ENST00000404395; ENSP00000384943; ENSG00000168610. [P40763-2] ENST00000585517; ENSP00000467000; ENSG00000168610. [P40763-3] ENST00000588969; ENSP00000467985; ENSG00000168610. [P40763-1] |
| GeneIDi | 6774. |
| KEGGi | hsa:6774. |
| UCSCi | uc002hzl.2. human. [P40763-1] |
Keywords - Coding sequence diversityi
Alternative splicing, PolymorphismSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | STAT3_HUMAN | |
| Accessioni | P40763Primary (citable) accession number: P40763 Secondary accession number(s): A8K7B8 Q9BW54 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | February 1, 1995 |
| Last sequence update: | June 7, 2004 | |
| Last modified: | July 5, 2017 | |
| This is version 194 of the entry and version 2 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Keywords - Technical termi
3D-structure, Complete proteome, Reference proteomeDocuments
- Human chromosome 17
Human chromosome 17: entries, gene names and cross-references to MIM - Human entries with polymorphisms or disease mutations
List of human entries with polymorphisms or disease mutations - Human polymorphisms and disease mutations
Index of human polymorphisms and disease mutations - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - SIMILARITY comments
Index of protein domains and families
